Evidence map›Paper›PMID 40830946›Full record

ArticleBMC medical informatics and decision making2025

A machine learning approach to predict self-efficacy in breast cancer survivors.

İsmail Toygar, Su Özgür, Gülcan Bağçivan, Ezgi Karaçam, Hilal Benzer, Ferda Akyüz Özdemir, Halise Taşkın Duman, Özlem Ovayolu

Abstract read
In one paragraph

Article in BMC medical informatics and decision making, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

İsmail Toygar *Fethiye Faculty of Health Sciences, Muğla Sıtkı Koçman University, Fethiye, Muğla, 48330, Turkey. ismail.toygar1@gmail.com.ORCID 0000-0003-3065-5756
Su Özgür *Ege University Faculty of Medicine, EgeSAM-Translational Pulmonary Research Center, Bornova, İzmir, 35100, Turkey.ORCID 0000-0002-8993-674X
Gülcan BağçivanKoç University Faculty of Nursing, İstanbul, 34010, Turkey.ORCID 0000-0002-9585-6332
Ezgi KaraçamDr Sadi Konuk Training and Research Hospital, İstanbul, 30110, Turkey.ORCID 0000-0002-6345-0725
Hilal BenzerHasan Kalyoncu University Vocational School, Şahinbey, Gaziantep, 27410, Turkey.ORCID 0000-0001-8046-6350
Ferda Akyüz ÖzdemirFethiye Faculty of Health Sciences, Muğla Sıtkı Koçman University, Fethiye, Muğla, 48330, Turkey.ORCID 0000-0001-9109-3692
Halise Taşkın DumanFethiye Faculty of Health Sciences, Muğla Sıtkı Koçman University, Fethiye, Muğla, 48330, Turkey.ORCID 0000-0003-1376-8556
Özlem OvayoluGaziantep University Faculty of Health Sciences, Şahinbey, Gaziantep, 27410, Turkey.ORCID 0000-0002-7335-4032

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo determine predictors of self-efficacy in breast cancer survivors and identify vulnerable groups.

methodsThis descriptive study was conducted between November 2023 and April 2024 at three hospitals in Türkiye and involved 430 breast cancer survivors. Data were collected through face-to-face surveys using a patient identification form and the Breast Cancer Survivor Self-Efficacy Scale. This study identified patient characteristics that indicate a tendency towards higher self-efficacy using four machine learning models; Logistic Regression (LR), Random Forest (RF), Support Vector Machine (SVM), XGBoost (XGB).

resultsThe mean age of participants was 50.7 ± 11.5 years. Majority of the participants (n = 425) were female. AUC values were used as ranker for the machine learning models. The ranks of the models were as follows; logistic regression model (0.715), RF (0.710), SVM (0.704), and XGBoost (0.694). Education level ranked first in the LR (0.3874), RF (0.3290), and SVM (0.1250) models, and was the second most important variable in the XGB (0.2327) model. Conversely, the cancer stage stood out in the LR (0.2466) and RF (0.1935) models, ranking third and fourth, respectively, while it ranked third in SVM (0.0683) and fourth in XGB (0.1872). Additionally, comorbidity ranked third in importance in the LR (0.2213) and RF (0.1681) models, but second in SVM (0.0705) and seventh in XGB (0.1393).

conclusionThe study demonstrated that the self-efficacy of breast cancer survivors was associated with their sociodemographic and medical characteristics. These characteristics may assist healthcare professionals in enhancing the care provided to breast cancer survivors. It is of the utmost importance to consider the aforementioned patient group as being vulnerable with regard to breast cancer survivor self-efficacy. There is a clear need for a focus on this vulnerable cohort.

Indexed as

Breast NeoplasmsCancer SurvivorsMachine LearningSelf EfficacyAdultAgedFemaleHumansMiddle AgedTurkeyBreast cancerMachine learningSelf-efficacySurvivorship

Identifiers

PMID40830946
PMCPMC12366306

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.